REDUCEDT+30
Kenney Stephanie
Atrium Therapeutics Inc · NASDAQ
−2,375 sh · $21.3K
Filed 22 Sept 2026SEC Form 4view source
Kenney Stephanie
Atrium Therapeutics Inc · NASDAQ
−2,375 sh · $21.3K
Hughes Steven George
Atrium Therapeutics Inc · NASDAQ
−21,459 sh · $192.1K
Younis Husam
Atrium Therapeutics Inc · NASDAQ
−11,216 sh · $100.4K
Gallagher Kathleen P.
Atrium Therapeutics Inc · NASDAQ
−11,632 sh · $104.1K
Winslow Brendan R.
Atrium Therapeutics Inc · NASDAQ
−6,742 sh · $60.3K
Flanagan W. Michael
Atrium Therapeutics Inc · NASDAQ
−22,812 sh · $204.2K
Boyce Sarah
Atrium Therapeutics Inc · NASDAQ
−126,418 sh · $1.1M
Hoyos Rocio Martin
Atrium Therapeutics Inc · NASDAQ
−8,320 sh · $74.5K
Two Sigma Investments
Atrium Therapeutics Inc · NASDAQ
178,560 sh · $2.4M